Clinical Trial Update: The Drug-drug Interaction of SP2086 and Metformin [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating the drug–drug interaction between SP2086 and metformin in adults with type 2 diabetes mellitus has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• SP2086
• metformin (metformin)

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Type 2 Diabetes | Phase 1 | Status: COMPLETED